Truncated: latest AI news

Thursday 5 November

Configure, Certify, and Operate Kubernetes GPU Clusters with NVIDIA DSX OS

Glowing green modular cube with gauge, clock, and gear icons on a black background.

AI-generated summary NVIDIA released the NVIDIA DSX AI Factory Platform and NVIDIA DSX OS as open source software licensed under Apache 2.0 to help configure and maintain accelerated Kubernetes infrastructure. NVIDIA says the open source software layer includes tools such as AICR, NVCRE, and NVSentinel to manage cluster baselines, workload validation, and ongoing health monitoring.

Bitcoin Erases Election Rally as AI Stocks Plunge, $428 Million in Crypto Longs Get Wiped Out

investing finance money bitcoin Breaking Push cryptocurrency stocks trading

AI-generated summary Bitcoin fell back toward $76,500 on Thursday as a broader technology stock selloff triggered $428 million in cryptocurrency liquidations. Investors expressed concerns over artificial intelligence spending, interest rates, and potential policy changes following the recent election.

Also covered by coindesk.com pcgamer.com www.theblock.co
+7 moreinvestingLive Yahoo Finance crypto.news Investing.com Fortune Bloomberg blockchain.news

Five Ways NVIDIA Co-Design Maximizes the Value of Every Byte in the AI Factory

AI-generated summary NVIDIA says its Vera Rubin NVL72 delivers up to thirty times the throughput per megawatt of GB300 NVL72 at one hundred sixty tokens per second per user on SemiAnalysis AgentX. NVIDIA says NVFP4 reduces the model footprint by approximately three point five times relative to FP16 and one point eight times relative to FP8.

Also covered by NVIDIA Blog IT Pro blockchain.news

UK Sovereign AI fund and Stripe CEO back Potential Sciences in multi-million-dollar raise

AI-generated summary London-based startup Potential Sciences has secured a multi-million-dollar seed funding round backed by the UK government's Sovereign AI fund and Stripe CEO Patrick Collison. The company builds artificial intelligence infrastructure for scientific drug discovery by leveraging quantum chemistry simulations and fundamental laws of physics.